Cargando…
Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines
Gemcitabine (GEM) is currently the standard option for the treatment of pancreatic cancer but its short half-life and rapid metabolism has caused for new modality for delivery of GEM. The purpose of this study was to formulate GEM loaded PEGylated thermosensitive liposomal nanoparticles (GEM-TSLnps)...
Autores principales: | Affram, Kevin, Udofot, Ofonime, Agyare, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469203/ https://www.ncbi.nlm.nih.gov/pubmed/26090123 |
Ejemplares similares
-
Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging
por: Affram, Kevin, et al.
Publicado: (2017) -
Development of a novel approach to enhance the solubility of ftibamzone formulation
por: Udofot, Ofonime, et al.
Publicado: (2014) -
Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
por: Inkoom, Andriana, et al.
Publicado: (2020) -
Comparative study on contrast enhancement of Magnevist and Magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI
por: Affram, Kevin, et al.
Publicado: (2020) -
Cytotoxic effects of Gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells
por: Celano, Marilena, et al.
Publicado: (2004)